Background: The Brief, 21-item version of the Prodromal Questionnaire (PQ-B) is a promising screener for psychosis-risk states that could be implemented in routine clinical practice. In this study, we assessed psychometric properties of the Italian version of the PQ-B (iPQ-B) in a sample of 243 help-seekers, aged 13–35 years. Sampling and Methods: After completing the iPQ-B, participants were assessed with the Comprehensive Assessment of At-Risk Mental States (CAARMS). Diagnostic accuracy (sensitivity, specificity, positive and negative predictive values [PPV and NPV], positive and negative likelihood ratios) and concurrent validity between PQ-B and CAARMS were determined using Cronbach’s alpha and Cohen’s kappa. We also tested the validity of the adopted PQ-B cut-offs through Receiver Operating Characteristic (ROC) curves plotted against CAARMS diagnoses and the predictive validity of the iPQ-B at 1-year follow-up. Results: The iPQ-B showed high internal consistency (Cronbach’s alpha = 0.868), acceptable diagnostic accuracy and concurrent validity (70% sensitivity, 67% specificity, 81% PPV, Cohen’s kappa = 0.335). ROC analyses pointed to threshold of ≥20 on the PQ-B total distress score as best cut-off. After 12 months of follow-up, 11% of participants who scored ≥4 on the PQ-B distressing item total score and did not meet CAARMS psychosis criteria at baseline, developed a psychotic disorder. Interestingly, age had significant negative correlations with iPQ-B scores and adolescents (aged < 18 years) showed higher iPQ-B scores than young adults. Conclusions: Overall, the psychometric properties of the iPQ-B were satisfactory. As iPQ-B scores appeared inversely associated to age, age-tailored cut-off scores are recommended for screening purposes in child-adolescent cohorts.

1.
Fusar-Poli P, Bonoldi I, Yung AR, Borgwardt S, Kempton MJ, Valmaggia L, Barale F, Caverzasi E, McGuire P: Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk. Arch Gen Psychiatry 2012; 69: 220–229.
2.
Savill M, D’Ambrosio J, Cannon TD, Loewy RL: Psychosis risk screening in different populations using the Prodromal Questionnaire: a systematic review. Early Interv Psychiatry 2018; 12: 3–14.
3.
Yung AR, Yuen HP, McGorry PD, Phillips LJ, Kelly D, Dell’Olio M, Francey SM, Cosgrave EM, Killackey E, Stanford C, Godfrey K, Buckby J: Mapping the onset of psychosis: the comprehensive assessment of at-risk mental states. Aust N Z J Psychiatry 2005; 39: 964–971.
4.
Miller TJ, McGlashan TH, Rosen JL, Cadenhead K, Cannon TD, Ventura J, McFarlane W, Perkins DO, Pearlson GD, Woods SW: Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr Bull 2003; 29: 703–715.
5.
Fusar-Poli P, Cappucciati M, Rutigliano G, Schultze-Lutter F, Bonoldi I, Borgwardt S, Riecher-Rossler A, Addington J, Perkins D, Woods SW, McGlashan TH, Klosterkotter J, Yung AR, McGuire P: At risk or not at risk? A meta-analysis of the prognostic accuracy of psychometric interviews for psychosis prediction. World Psychiatry 2015; 14: 322–332.
6.
Brandizzi M, Schultze-Lutter F, Masillo A, Lanna A, Curto M, Fortes Lindau J, -Solfanelli A, Listanti G, Patanè M, Kotzalidis G, Gebhardt E, Meyer N, Di Pietro D,  -Leccisi D, Girardi P, Fiori Nastro P: Self-reported attenuated psychotic-like experiences in help-seeking adolescents and their association with age, functioning and psychopathology. Schizoph Res 2014; 160: 110–117.
7.
Addington J, Stowkowy J, Weiser M: Screening tools for clinical high risk for psychosis. Early Interv Psychiatry 2015; 9: 345–356.
8.
Kline E, Schiffman J: Psychosis risk screening: a systematic review. Schizophr Res 2014; 158: 11–18.
9.
Loewy RL, Bearden CE, Johnson JK, Raine A, Cannon TD: The prodromal questionnaire (PQ): preliminary validation of a self-report screening measure for prodromal and psychotic syndromes. Schizophr Res 2005; 79: 117–125.
10.
Rietdijk J, Klaassen R, Ising H, Dragt S, Nieman DH, van de Kamp J, Cuijpers P, Linszen D, van der Gaag M: Detection of people at risk of developing a first psychosis: comparison of two recruitment strategies. Acta Psychiatr Scand 2012; 126: 21–30.
11.
Loewy RL, Pearson R, Vinogradov S, Bearden CE, Cannon TD: Psychosis risk screening with the prodromal questionnaire – brief version. Schizophr Res 2011; 129: 42–46.
12.
Fonseca-Pedrero E, Gooding DC, Ortuno-Sierra J, Paino M: Assessing self-reported clinical high risk symptoms in community-derived adolescents: a psychometric evaluation of the prodromal questionnaire-Brief. Compr Psychiatry 2016; 66: 201–208.
13.
Fonseca-Pedrero E, Gooding DC, Ortuno-Sierra J, Pflum M, Paino M, Muniz J: Classifying risk status of non-clinical adolescents using psychometric indicators for psychosis spectrum disorders. Psychiatry Res 2016; 243: 246–254.
14.
Raballo A, Corrias I, Petretto DR, Preti A: Quick identification of the risk of psychosis: the Italian version of the brief prodromal questionnaire. Early Interv Psychiatry 2014; 8(suppl 1):s64.
15.
Raballo A, Chiri LR, Pelizza L, Fontana F, Favazzo R, Pensieri L, Fabiani M, Cioncolini L, Scazza I, Paterlini F, Semrov E: Field-testing the early intervention paradigm in emilia-romagna: the reggio emilia at risk mental state (ReARMS) project. Early Interv Psychiatry 2014; 8(suppl 1):s88.
16.
Jablensky A, Sartorius N, Ernberg G, Anker M, Korten A, Cooper JE, Day R, Bertelsen A: Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study. Psychol Med Monogr 1992;(suppl 20): 1–97.
17.
Raballo A, Semrov E, Bonner Y, Simmons MB: Traduzione e adattamento italiano della CAARMS (the Comprehensive Assessment of At Risk Mental States). Bologna, Regione Emilia-Romagna, 2013.
18.
Pancheri P, Brugnoli R, Carilli L, Delle Chiaie R, Marconi PL, Petrucci RM: Valutazione dimensionale della sintomatologia schizofrenica: validazione della versione italiana della scala per la valutazione dei sintomi positivi e negativi (PANSS). J Psychopathology 1995; 1: 60–75.
19.
Preti A, Raballo A: PQ-B: Authorized Italian Version. Cagliari, Studio CAPIRE (Cagliari-Psychosis Investigation on Risk Emergence), 2011.
20.
Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleithen J: The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003; 3: 25.
21.
Whiting P, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, Leeflang MM, Sterne JA, Bossuyt PM: QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 2001; 155: 529–536.
22.
Kline E, Thompson E, Bussell K, Pitts SC, Reeves G, Schiffman J: Psychotic-like experiences and distress among adolescents using mental health services. Schizophr Res 2014; 152: 498–502.
23.
Thompson E, Kline E, Reeves G, Pitts SC, Schiffman J: Identifying youth at risk for psychosis using the behavior assessment system for children. Schizophr Res 2013; 151: 238–244.
24.
International Test Commission (ITC): ITC Guidelines for Translating and Adapting Test, (ed 2). ITC Press (www.InTestComm.org), 2017.
25.
SPSS Inc.: SPSS for Windows, rel. 18.0. Chicago, SPSS Inc., 2010.
26.
R Development Core Team: A language and environment for statistical computing. R Foundation for statistical computing retrieved from https//www.R-project.org. Vienna (Austria), 2013.
27.
Green SB, Yang Y, Alt M, Brinkley S, Gray S, Hogan T, Cowan N: Use of internal consistency coefficients for estimating reliability of experimental task scores. Psychon Bull Rev 2016; 23: 750–763.
28.
Dunn TJ, Baguley T, Brunsden V: From alpha to Omega: a practical solution to the pervasive problem of internal consistency estimation. Br J Psychol 2014; 105: 399–412.
29.
Jaeschke R, Guyatt G, Sackett DL: Users’ guides to the medical literature – III. How to use an article about a diagnostic test – A. Are the results of the study valid? Evidence-based medicine working group. JAMA 1994; 271: 389–391.
30.
Zhou X, Obuchowski NA, McClish DK: Statistical Methods in Diagnostic Medicine. New York, Wiley and sons, 2002.
31.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, IV Edition, text revised. Washington, APA Press, 2000.
32.
Landis JR, Koch GG: The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159–174.
33.
Xu L, Zhang T, Zheng L, Li H, Tang Y, Luo X, Sheng J, Wang J: Psychometric properties of Prodromal Questionnaire- Brief version among Chinese help-seeking individuals. Plos One 2016; 11.
34.
Kotzalidis GD, Solfanelli A, Piacentino D, Savoja V, Fiori Nastro P, Curto M, Lindau JF, Masillo A, Brandizzi M, Fagioli F, Raballo A, Gebhardt E, Preti A, D’Alema M, Fucci MR, Miletto R, Andropoli D, Leccisi D, Girardi P, Loewy RL, Schultze-Lutter F: The Italian version of the 92-item Prodromal Questionnaire: concurrent validity with the SIPS and factor analysis in a sample of 258 outpatients aged 11–36 years. Schizophr Res 2017; 189: 50–56.
35.
Ising HK, Veling W, Loewy RL, Rietveld MW, Rietdijk J, Dragt S, Klaassen RMC, Nieman DH, Wunderink L, Linszen DH, van der Gaag M: The validity of the 16-item version of the prodromal questionnaire (PQ-16) to screen for Ultra-High Risk of developing psychosis in the general help-seeking population. Schizophr Bull 2012; 38: 1288–1296.
36.
Schultze-Lutter F, Michel C, Schmidt SJ, Schimmelmann BJ, Maric MP, Salokangas RKR, Riecher-Rossler A, van der Gaag M, Nordentoft M, Raballo A, Meneghelli A, Marshall M, Morrison A, Ruhrmann S, Klosterkotter J: EPA guidance on the -early detection of clinical high risk states of psychoses. Eur Psychiatry 2015; 30: 405–416.
37.
Pelizza L, Azzali S, Paterlini F, Garlassi S, Scazza I, Chiri LR, Poletti M, Pupo S, -Raballo A: Screening for psychosis risk among help-seeking adolescents: application of the Italian version of the 16-item prodromal questionnaire (iPQ-16) in child and adolescent neuropsychiatry services. Early Interv Psychiatry 2017, Epub ahead of print.
38.
Kelleher I, Connor D, Clarke MC, Devlin N, Harley M, Cannon M: Prevalence of psychotic symptoms in childhood and adolescence: a systematic review and meta-analysis of population-based studies. Psychol Med 2012; 42: 1857–1863.
39.
Chen F, Wang L, Wang J, Heeramun-Aubeeluck A, Yuan J, Zhao X: Applicability of the Chinese version of the 16-item Prodromal Questionnaire (CPQ-16) for identifying attenuated psychosis syndrome in a college population. Early Interv Psychiatry 2016; 10: 308–315.
40.
Preti A, Cella M, Raballo A, Vellante M: Psychotic-like or unusual subjective experiences? The role of certainty in the appraisal of the subclinical psychotic phenotype. Psychiatry Res 2012; 200: 669–673.
41.
Valmaggia LR, McCrone P, Knapp M, Woolley JB, Broome MR, Tabraham P, Johns LC, Prescott C, Bramon E, Lappin J, Power P, McGuire PK: Economic impact of early intervention in people at high risk of psychosis. Psychol Med 2009; 39: 1617–1626.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.